¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Amino Acid Multiple Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • hydroxyindoleacetic acid
    È÷µå·Ï½ÃÀε¹¾Æ¼¼Æ®»ê
  • isothiocyanic acid
    ÀÌ¼ÒÆ¼¿À½Ã¾È»ê
  • inosinic acid
    À̳ë½Å»ê
  • ketonic acid
    ÄÉÅæ»ê
  • lauric acid
    ·Î¸£»ê
  • leuconic acid
    ·ùÄÜ»ê
  • lichenic acid
    ÁöÀÇ»ê
  • linoleic acid
    ¸®³î·¹»ê
  • linolenic acid
    ¸®³î·»»ê
  • linolic acid
    ¸®³î»ê
  • lipoic acid
    ¸®Æ÷»ê
  • lactic acid
    Á¥»ê
  • mixed acid
    È¥ÇÕ»ê
  • maleic acid
    ¸»·¹»ê
  • malic acid
    ¸»»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
  • nitric acid
    Áú»ê
  • nitrobenzoic acid
    ³ªÀÌÆ®·Îº¥Á¨»ê
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    Áú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
  • oleic acid
    ¿Ã·¹»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • oxaloacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • propionic acid
    ÇÁ·ÎÇǿ»ê(¡­ß«).
  • prostatic acid phosphatase
    Àü¸³¼±»êÀλêÈ¿¼Ò(Æ÷½ºÆÄŸÁ¦)(îñí¡àÍß«×òß«ý£áÈ)
  • pteroylmonoglutamic acid
    Å×·ÎÀϸð³ë±Û·çŽ»ê(¡­ß«)
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê(¡­ß«).
  • pyroligneous acid
    ¸ñÃÊ»ê(ÙÊõ³ß«).
  • pyrophosphoric acid
    ÇÇ·ÎÀλê(¡­ìÝß«).
  • pyrosulfuric acid
    ÇÇ·ÎȲ»ê(¡­üÜß«).
  • pyrotartarid acid
    ÇǷΟ¸£Å¸¸£»ê(¡­ß«).
  • pyruvic acid
    ÇÇ·çºó»ê(¡­ß«).
  • pyuria, acid
    »ê¼º³ó´¢
  • regulation of acid base equilibrium
    »ê-¿°±âÆòÇüÁ¶Àý(ß«ç¤ÐñøÁû¬ðàï½).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • oral anatomy
    ±¸°­ÇغÎÇÐ(Ϣ˷ú°ÜøùÊ).
  • oral angle
    ÀÔ¼ú±¸¼®
  • oral angle
    ÀÔ²¿¸®
  • oral angle
    ÀÔ²¿¸®
  • oral anticoagulant
    °æ±¸Ç×ÀÀÇ÷¾à(ÌèÏ¢ù÷ ëêúìå·).
  • oral anticoagulant
    °æ±¸Ç×ÀÀÇ÷¾à(˭˴̰ ËôÌ´Ëâ).
  • oral anticoagulant
    °æ±¸Ç×ÀÀÇ÷¾à(ÌèÏ¢ù÷ëêúìå·).
  • oral arch
    ±¸°³±Ã, ÀÔ±Ã
  • oral arch
    ÀÔ±Ã, ±¸°³±Ã(Ï¢ËÏÏá).
  • oral atresia ³ª a. oris, atretostomia
    (¼±Ãµ¼º) ±¸°­Æó¼â(Áõ)(à»ô¸àõϢ˷øÍáðñø).
  • oral atresia ³ª a. oris, atretostomia
    (¼±Ãµ¼º) ±¸°­Æó¼â(Áõ)((à»ô¸àõ) Ϣ˷øÍáð(ñø))
  • oral bacteria
    ±¸°­¼¼±Õ
  • oral bacteria
    ±¸°­¼¼±Õ(Ϣ˷á¬Ð¶).
  • oral bacteriology
    ±¸°­¼¼±ÕÇÐ(Ϣ˷á¬Ð¶ùÊ).
  • oral bacterium
    ±¸°­¼¼±Õ(Ϣ˷á¬Ð¶).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • hippuric acid
    ¸¶´¢»ê(Ø©Òãß«)
  • homoamino acid
    È£¸ð¾Æ¹Ì³ë»ê(ß«)
  • homofermentative lactic acid bacteria
    µ¿Á¾¹ßÈ¿(ÔÒðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • homogentisic acid
    È£¸ðÁ¨Æ¾»ê(ß«)
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(ß«)
  • hydroxy acid
    ÇÏÀ̵å·Ï½Ã»ê(ß«)
  • ¥â-hydroxybutyric acid
    ¥â-ÇÏÀ̵å·Ï½ÃºäƼ¸£»ê(ß«)
  • 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê(ß«)
  • imino acid
    À̹̳ë»ê(ß«)
  • indoleacetic acid
    Àε¹¾Æ¼¼Æ®»ê(ß«)
  • infectious nucleic acid
    °¨¿°¼ºÇÙ»ê(Êïæøàõú·ß«)
  • inosinic acid
    À̳ë½Å»ê(ß«)
  • isoascorbic acid
    ¾ÆÀ̼ҾƽºÄÚ¸£ºó»ê
  • isocitric acid
    ¾ÆÀ̼һçÀÌÆ®¸£»ê(ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
CAA carotid audiofrequency analysis; cerebral amyloid angiopathy; circulating anodic antigen; Clean Air ...
Fd the amino-terminal portion of the heavy chain of an immunoglobulin molecule; ferredoxin
NAAP N-acetyl-4-amino-phenazone
Nt amino terminal
OKT ornithine ketoacid amino-transferase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
OLP Oral Lichen Planus
OPV Oral Polio Vaccine
OPV Oral Poliomyelitis Vaccine
OPV Oral Poliovirus Vaccine
ORS Oral Rehydration Salts
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ethacrynic acid
    ¿¡Å¸Å©¸°»ê
  • ethylene-diamin tetra-acetic acid
    ¿¡Æ¿·»µð¾Æ¹Î »ç-¾Æ¼¼Æ®»ê
    ¹é»öÀÇ ºÐ¸»·Î Á߱ݼÓ. ¾ËÄ®¸®Åä ±Ý¼Ó µî°ú È­ÇÕÇÏ¿© Àß ³ì´Â ¸Å¿ì ¾ÈÁ¤µÈ Ű·¹ÀÌÆ® È­ÇÕ¹°À» ¸¸µé°í, ¹æ»ç¼º ¿ø¼ÒÀÇ Å»¿À¿°. ¹°ÀÇ °æµµ ºñ»ö ºÐ¼®. ±Ý¼ÓÀÇ ¿ë·® ºÐ¼® µî¿¡ »ç¿ëµÇ¸ç, ÃÖ±Ù¿¡´Â Ç÷¾×À» ÀúÀåÇϴµ¥ ÷»çÇϸé Ç×ÀÀ°í¼º°ú º¸Á¸ ±â°£ÀÇ ¿¬ÀåÀ» °¡´ÉÄÉ ÇÑ´Ù´Â °ÍÀÌ ÆÇ¸íµÇ¾ú´Ù.
  • fatty acid cyclooxygenase
    Áö¹æ»ê »çÀÌŬ·Î¿Á½ÃÁö³×À̽º
  • folic acid antagonist
    ¿±»ê ±æÇ×Á¦
  • folic acid deficiency anemia
    ¿±»ê °áÆð¼º ºóÇ÷
  • formic acid
    Æ÷¸§»ê, °³¹Ì»ê, ÀÇ»ê
  • formiminoglutamic acid
    Æ÷¸£¹Ì¹Ì³ë±Û·çŸ¹Í »ê
    ±Û·çŸ¹Î»êÀÌ È÷½ºÆ¼Æ¾À¸·Î ºÐÇØµÇ´Â °ú Á¤ÀÇ Áß°£ »ê¹°ÀÌ´Ù.
  • free acid
    À¯¸® »ê
  • free fatty acid
    À¯¸® Áö¹æ»ê
  • fumaric acid
    Ǫ¸¶¸£ »ê
    ºÒÆ÷È­ ÀÌ¿°±â»ê. Æ®¶óÀÌ Ä«¸£º¹½Ç»ê ȸ·ÎÀÇ Áß°£Ã¼.
  • humic acid
    È޹λê
  • humus acid
    ºÎ½Ä »ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
    ÁÖÁ¶¹° ¼¼Ã´ ¿ë¾×À¸·Î »ç¿ëµÇ´Â »ê ¿ë¾×.
  • isoniazid : 1. 4-pyridinecarboxylic acid hydrazide. ¹«»ö ¶Ç´Â ¹é»öÀÇ °áÁ¤À̳ª ºÐ¸». °áÇÙ Ä¡·á¿¡ »ç¿ëµÇ¸ç, ³»º¹ ¶Ç´Â ±ÙÀ°¿¡ ÁÖ»çÇÑ´Ù. 2. °áÇÙ±Õ¿¡ ´ëÇÑ È­ÇÐ ¿ä¹ý ¾àÀÇ Çϳª·Î 1Â÷ Ç×°áÇÙÁ¦·Î ¾²ÀδÙ. Àå±â Åõ¿©°¡ µÇ¹Ç·Î ºÎÀÛ¿ë Æ¯È÷ ½Å°æ, ¼ÒÈ­±â Àå¾Ö¿¡ ÁÖÀǸ¦ ¿ä
    µ¿Á¾ µ¶ ¿ä¹ý
    ÁúȯÀÇ »ý»ê¹° ¶Ç´Â ÀÌȯ Àå±â·ÎºÎÅÍ ÃßÃâÇÏ¿© ¸¸µç ¹°Áú·Î ÁúȯÀ» Ä¡·áÇÏ´Â ¹æ¹ý.
  • J acid

    Á¦ÀÌ »ê
    ¿°·áÀÇ Áß°£Ã¼.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
multiple system atrophy A name grouping together the four cerebral degenerative diseases of olivopontocerebellar atrophy, shy-drager syndrome, striatonigral degeneration, and one form of parkinson disease, considering them different forms of the same disease process.
(12 Dec 1998)
multiple trauma Physical insults or injuries occurring simultaneously in several parts of the body.
(12 Dec 1998)
multiple vision polyopia
hamartoma syndrome, multiple A hereditary disease characterised by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.
(12 Dec 1998)
pregnancy, multiple The condition of bearing two or more foetuses simultaneously.
(12 Dec 1998)
hereditary multiple exostoses A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
hereditary multiple trichoepithelioma <tumour> Multiple small benign nodules, occurring mostly on the skin of the face, derived from basal cells of hair follicles enclosing small keratin cysts; frequent autosomal dominant inheritance.
Synonym: acanthoma adenoides cysticum, Brooke's tumour, epithelioma adenoides cysticum, hereditary multiple trichoepithelioma.
Origin: tricho-+ epithelioma
(05 Mar 2000)
sclerosis, multiple The National Multiple Sclerosis Society says of ms that it is a disease that randomly attacks your central nervous system, wearing away the control you have over your body. Symptoms may range from numbness to paralysis and blindness. The progress, severity and specific symptoms cannot be foreseen. You never know when attacks will occur, how long they will last, or how severe they will be. most people are diagnosed with ms between the ages of 20 and 40. In medical terms, ms involves demyelinization of the white matter sometimes extending into the gray matter. Demyelinization is loss of myelin, the coating of nerve fibres composed of lipids (fats) and protein that serves as insulation and permits efficient nerve fibre conduction. The white matter is the part of the brain which contains myelinated nerve fibres and appears white, whereas the gray matter is the cortex of the brain which contains nerve cell bodies and appears gray. When myelin is damaged in ms, nerve fibre conduction is faulty or absent. Impaired bodily functions or altered sensations associated with those demyelinated nerve fibres give rise to the symptoms of ms. Recent research (1998) has also identified nerve cell death as part of the nervous system injury in ms.
(12 Dec 1998)
psychotherapy, multiple The use of more than one therapist at one time in individual or group psychotherapy.
(12 Dec 1998)
neoplasms, multiple primary Two or more abnormal growths of tissue occurring simultaneously. The neoplasms are histologically different and may be found in the same or different sites.
(12 Dec 1998)
drug resistance, multiple Simultaneous resistance to a broad spectrum of structurally and functionally distinct drugs following exposure to a single agent. It is thought to result from the overexpression of genes encoding an integral plasma membrane protein, p-glycoprotein.
(12 Dec 1998)
exostoses, multiple hereditary Hereditary disorder transmitted by an autosomal dominant gene and characterised by multiple exostoses (multiple osteochondromas) near the ends of long bones. The genetic abnormality results in a defect in the osteoclastic activity at the metaphyseal ends of the bone during the remodeling process in childhood or early adolescence. The metaphyses develop benign, bony outgrowths often capped by cartilage. A small number undergo neoplastic transformation.
(12 Dec 1998)
familial multiple endocrine adenomatosis The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance.
Synonym: multiple endocrine adenomatosis.
(05 Mar 2000)
law of multiple proportions The relative weights in which two substances form a chemical union singly with a third are the same as, or simple multiples of, those in which they unite with each other; a corollary of the law of definite proportions.
Synonym: law of multiple proportions.
(05 Mar 2000)
lipomatosis, multiple symmetrical Multiple circumscribed or encapsulated lipomas which may be distributed symmetrically or haphazardly or which may form a collar around the neck.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á